These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 33230874)
1. Genomic mutational profiling of circulating tumour DNA in metastatic angiosarcoma. Tanaka K; Myangat TM; Sawamura S; Otsuka-Maeda S; Sakamoto R; Kanazawa-Yamada S; Kanemaru H; Makino K; Aoi J; Kajihara I; Ihn H J Eur Acad Dermatol Venereol; 2021 Apr; 35(4):e293-e295. PubMed ID: 33230874 [No Abstract] [Full Text] [Related]
2. Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer. Nong J; Gong Y; Guan Y; Yi X; Yi Y; Chang L; Yang L; Lv J; Guo Z; Jia H; Chu Y; Liu T; Chen M; Byers L; Roarty E; Lam VK; Papadimitrakopoulou VA; Wistuba I; Heymach JV; Glisson B; Liao Z; Lee JJ; Futreal PA; Zhang S; Xia X; Zhang J; Wang J Nat Commun; 2018 Aug; 9(1):3114. PubMed ID: 30082701 [TBL] [Abstract][Full Text] [Related]
3. Mutational status of K-ras and TP53 genes in primary sarcomas of the heart. Garcia JM; Gonzalez R; Silva JM; Dominguez G; Vegazo IS; Gamallo C; Provencio M; EspaƱa P; Bonilla F Br J Cancer; 2000 Mar; 82(6):1183-5. PubMed ID: 10735503 [TBL] [Abstract][Full Text] [Related]
4. Case report: whole exome sequencing of primary cardiac angiosarcoma highlights potential for targeted therapies. Zhrebker L; Cherni I; Gross LM; Hinshelwood MM; Reese M; Aldrich J; Guileyardo JM; Roberts WC; Craig D; Von Hoff DD; Mennel RG; Carpten JD BMC Cancer; 2017 Jan; 17(1):17. PubMed ID: 28056866 [TBL] [Abstract][Full Text] [Related]
5. Comparative Analysis of Genomic Alterations across Castration Sensitive and Castration Resistant Prostate Cancer via Circulating Tumor DNA Sequencing. Fan L; Fei X; Zhu Y; Pan J; Sha J; Chi C; Gong Y; Du X; Zhou L; Dong B; Xue W J Urol; 2021 Feb; 205(2):461-469. PubMed ID: 32897803 [TBL] [Abstract][Full Text] [Related]
6. Comparative Genomic Profiling of Refractory and Metastatic Penile and Nonpenile Cutaneous Squamous Cell Carcinoma: Implications for Selection of Systemic Therapy. Jacob JM; Ferry EK; Gay LM; Elvin JA; Vergilio JA; Ramkissoon S; Severson E; Necchi A; Killian JK; Ali SM; Schrock AB; Liu NW; Chung J; Miller VA; Stephens PJ; Welsh A; Corona RJ; Ross JS; Bratslavsky G J Urol; 2019 Mar; 201(3):541-548. PubMed ID: 30291913 [TBL] [Abstract][Full Text] [Related]
7. Detection of somatic RAS mutations in circulating tumor DNA from metastatic colorectal cancer patients: are we ready for clinical use? Montagut C; Tsui DW; Diaz LA Ann Oncol; 2018 May; 29(5):1083-1084. PubMed ID: 29554200 [No Abstract] [Full Text] [Related]
8. Circulating Tumor DNA Mutation Profiling by Targeted Next Generation Sequencing Provides Guidance for Personalized Treatments in Multiple Cancer Types. Shu Y; Wu X; Tong X; Wang X; Chang Z; Mao Y; Chen X; Sun J; Wang Z; Hong Z; Zhu L; Zhu C; Chen J; Liang Y; Shao H; Shao YW Sci Rep; 2017 Apr; 7(1):583. PubMed ID: 28373672 [TBL] [Abstract][Full Text] [Related]
9. Sequential development of hepatocellular carcinoma and liver angiosarcoma in a vinyl chloride-exposed worker. Guido M; Sarcognato S; Pelletti G; Fassan M; Murer B; Snenghi R Hum Pathol; 2016 Nov; 57():193-196. PubMed ID: 27544804 [TBL] [Abstract][Full Text] [Related]
10. Biallelic Hanna JA; Drummond CJ; Garcia MR; Go JC; Finkelstein D; Rehg JE; Hatley ME Cancer Res; 2017 Nov; 77(22):6109-6118. PubMed ID: 28916654 [TBL] [Abstract][Full Text] [Related]
11. DNA Methylation Profiling Identifies Distinct Clusters in Angiosarcomas. Weidema ME; van de Geer E; Koelsche C; Desar IME; Kemmeren P; Hillebrandt-Roeffen MHS; Ho VKY; van der Graaf WTA; Versleijen-Jonkers YMH; von Deimling A; Flucke UE; Clin Cancer Res; 2020 Jan; 26(1):93-100. PubMed ID: 31562204 [TBL] [Abstract][Full Text] [Related]
13. Mutation of the PTEN gene in a human hepatic angiosarcoma. Tate G; Suzuki T; Mitsuya T Cancer Genet Cytogenet; 2007 Oct; 178(2):160-2. PubMed ID: 17954274 [TBL] [Abstract][Full Text] [Related]
14. Chromosomal abnormalities and p53 gene mutation in a cardiac angiosarcoma. Zu Y; Perle MA; Yan Z; Liu J; Kumar A; Waisman J Appl Immunohistochem Mol Morphol; 2001 Mar; 9(1):24-8. PubMed ID: 11277410 [TBL] [Abstract][Full Text] [Related]
15. Liquid Biopsies for Monitoring Temporal Genomic Heterogeneity in Breast and Colon Cancers. Venesio T; Siravegna G; Bardelli A; Sapino A Pathobiology; 2018; 85(1-2):146-154. PubMed ID: 28614831 [TBL] [Abstract][Full Text] [Related]
16. Blood-based tumour mutational burden analysis in NSCLC. Das M Lancet Oncol; 2018 Sep; 19(9):e446. PubMed ID: 30122616 [No Abstract] [Full Text] [Related]
17. Phospholipase C gamma 1 (PLCG1) R707Q mutation is counterselected under targeted therapy in a patient with hepatic angiosarcoma. Prenen H; Smeets D; Mazzone M; Lambrechts D; Sagaert X; Sciot R; Debiec-Rychter M Oncotarget; 2015 Nov; 6(34):36418-25. PubMed ID: 26474454 [TBL] [Abstract][Full Text] [Related]
18. Alternative lengthening of telomeres phenotype in malignant vascular tumors is highly associated with loss of ATRX expression and is frequently observed in hepatic angiosarcomas. Liau JY; Tsai JH; Yang CY; Lee JC; Liang CW; Hsu HH; Jeng YM Hum Pathol; 2015 Sep; 46(9):1360-6. PubMed ID: 26190196 [TBL] [Abstract][Full Text] [Related]
19. Clinical Application of Genomic Profiling With Circulating Tumor DNA for Management of Advanced Non-Small-cell Lung Cancer in Asia. Loong HH; Raymond VM; Shiotsu Y; Chua DTT; Teo PML; Yung T; Skrzypczak S; Lanman RB; Mok TSK Clin Lung Cancer; 2018 Sep; 19(5):e601-e608. PubMed ID: 29807856 [TBL] [Abstract][Full Text] [Related]